Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin + Cefazolin for Post-Cesarean Endometritis
NCT01721616Phase 4Withdrawn
- Sponsor
- University of Missouri-Kansas City
- Start
- Nov 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azithromycin in endometritis (2 arms), sponsored by University of Missouri-Kansas City. Primary endpoint: Development of post cesarean endometritis. Planned start Nov 2012; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
endometritis
Beyond the preview
Go deeper on NCT01721616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01721616.